- Home
- GVP vs EDSA Comparison
GVP vs EDSA Comparison
Compare GVP & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVP
- EDSA
- Stock Information
- Founded
- GVP 1994
- EDSA 2015
- Country
- GVP United States
- EDSA Canada
- Employees
- GVP N/A
- EDSA N/A
- Industry
- GVP Computer Software: Prepackaged Software
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- GVP Technology
- EDSA Health Care
- Exchange
- GVP Nasdaq
- EDSA Nasdaq
- Market Cap
- GVP 14.2M
- EDSA 13.7M
- IPO Year
- GVP 1995
- EDSA N/A
- Fundamental
- Price
- GVP $4.06
- EDSA $4.28
- Analyst Decision
- GVP Strong Buy
- EDSA Strong Buy
- Analyst Count
- GVP 1
- EDSA 2
- Target Price
- GVP $13.00
- EDSA $39.00
- AVG Volume (30 Days)
- GVP 45.3K
- EDSA 8.9K
- Earning Date
- GVP 11-12-2024
- EDSA 08-09-2024
- Dividend Yield
- GVP N/A
- EDSA N/A
- EPS Growth
- GVP N/A
- EDSA N/A
- EPS
- GVP N/A
- EDSA N/A
- Revenue
- GVP $44,789,000.00
- EDSA N/A
- Revenue This Year
- GVP $29.76
- EDSA N/A
- Revenue Next Year
- GVP $10.48
- EDSA N/A
- P/E Ratio
- GVP N/A
- EDSA N/A
- Revenue Growth
- GVP N/A
- EDSA N/A
- 52 Week Low
- GVP $1.21
- EDSA $2.46
- 52 Week High
- GVP $5.38
- EDSA $8.33
- Technical
- Relative Strength Index (RSI)
- GVP 57.08
- EDSA 45.00
- Support Level
- GVP $4.02
- EDSA $4.20
- Resistance Level
- GVP $4.05
- EDSA $5.00
- Average True Range (ATR)
- GVP 0.04
- EDSA 0.23
- MACD
- GVP -0.01
- EDSA 0.01
- Stochastic Oscillator
- GVP 75.13
- EDSA 14.29
About GVP GSE Systems Inc.
GSE Systems Inc is a company engaged in providing engineering, staffing, and simulation software to clients in the power and process industries. It also provides interactive computer-based tutorials and simulation software for the refining, chemical, and petrochemical industries. It functions through two segments: The engineering segment and the Workforce Solutions segment. Its geographical segments include the United States, Europe, and Asia, out of which the majority of the revenue is generated from the United States.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.